In Brief: Copley
Executive Summary
Copley: VP-Scientific Affairs Jerome Skelly resigns. Skelly, who headed FDA's Division of Biopharmaceutics from 1983 to 1988, will continue to work for Copley as an outside R&D consultant. Copley is considering internal and external candidates for the VP position. The company is also considering whether further workforce reductions are necessary. Copley is scheduled for an initial appearance before Boston Federal Judge Joseph Tauro during the week of June 9 to review a $10.7 mil. fraud settlement reached with the U.S. Attorney's office. The generic drug maker is a subsidiary of Hoechst AG ("The Pink Sheet" June 2, T&G-10)...